Spots Global Cancer Trial Database for Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

Official Title: Pilot Study of Focal Salvage HDR Prostate Brachytherapy

Study ID: NCT01583920

Conditions

Prostate Cancer

Interventions

focal salvage HDR prostate brachytherapy

Study Description

Brief Summary: Radiation therapy is considered a standard treatment option for the management of localized prostate cancer. Among the 20-30% who recur, a proportion of them will present with an isolated local recurrence, meaning no distant metastases. If left untreated, it may serve as a source for subsequent metastases. Salvage options available for isolated local recurrence include; temporary or permanent implantation of radioactive seeds into the prostate, complete removal of the prostate gland, use of low temperatures to treat the disease, and high frequency ultrasound to treat the disease. There are risks of complications associated with all these treatments, and there is presently no consensus as to which treatment is the best. Therefore, the aim of this pilot study is to look at the feasibility and toxicities of focal treatment of the prostate using temporary implantation of radioactive seeds into the prostate which the investigators hope will be less since the entire prostate is not treated.

Detailed Description: